| The use of medications for inflammatory bowel disease during pregnancy and nursing. | |
MedLine Citation:
|
PMID: 16144504 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Inflammatory bowel disease includes two primary disorders, ulcerative colitis and Crohn's disease. These diseases mainly affect young adults, with a peak occurrence between 15 and 25 years of age. The causes of these diseases are largely unknown, with current treatments targeted against the heightened inflammatory response witnessed in the intestinal mucosa of both conditions. With the peak age ranges for pregnancy and inflammatory bowel disease overlapping, it is important to weigh the benefits of treating a mother during pregnancy against the potential risks to the fetus and the course of the pregnancy. This review examines the current safety data on medications used in women with inflammatory bowel disease during pregnancy. |
Authors:
|
Jenny Sauk; Sunanda Kane |
Related Documents
:
|
12635424 - Pregnancy and liver disease. 11426494 - Possibility of potential vwd misdiagnosis or misclassification using lia technology and... 12527454 - Maternal and perinatal outcome in rheumatic heart disease. 8842834 - Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel... 21465604 - The duration of persistent abnormal ductus venosus flow and its impact on perinatal out... 1770844 - Developing models to evaluate pregnancy outcomes. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 6 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2005 Sep |
Date Detail:
|
Created Date: 2005-09-07 Completed Date: 2006-06-26 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 1833-9 Citation Subset: IM |
Affiliation:
|
Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adrenal Cortex Hormones / adverse effects, therapeutic use* Adult Anti-Inflammatory Agents, Non-Steroidal / adverse effects, therapeutic use* Azathioprine / adverse effects, therapeutic use Breast Feeding Clinical Trials as Topic Colitis, Ulcerative / complications, drug therapy Crohn Disease / complications, drug therapy Female Fetus / drug effects Humans Immunosuppressive Agents / adverse effects, therapeutic use* Inflammatory Bowel Diseases / complications, drug therapy* Milk, Human / metabolism Pregnancy Pregnancy Complications / drug therapy* Pregnancy Outcome Prenatal Care Sulfasalazine / adverse effects, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Immunosuppressive Agents; 446-86-6/Azathioprine; 599-79-1/Sulfasalazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of androgens in hormone replacement therapy.
Next Document: Therapeutic management of hyperglycaemic hyperosmolar syndrome.